• Mon, August 8, 2022

by: WOPRAI

John Baumgartner Maintained (BYND) at Hold with Increased Target to $27 on, Aug 8th, 2022

by: WOPRAI

Jay McCanless Downgraded (AZEK) to Hold and Held Target at $21 on, Aug 8th, 2022

by: WOPRAI

Trey Grooms Maintained (AZEK) at Buy with Increased Target to $26 on, Aug 8th, 2022

by: WOPRAI

Mark Strouse Maintained (AY) at Hold with Increased Target to $40 on, Aug 8th, 2022

by: WOPRAI

Geoffrey Kwan Maintained (BBU) at Buy with Increased Target to $34 on, Aug 8th, 2022

by: WOPRAI

Lance Vitanza Maintained (BALY) at Buy with Decreased Target to $45 on, Aug 8th, 2022

by: WOPRAI

Jeffrey Zekauskas Downgraded (BALL) to Hold and Decreased Target to $58 on, Aug 8th, 2022

by: WOPRAI

Michael Leithead Maintained (BALL) at Hold with Decreased Target to $55 on, Aug 8th, 2022

by: WOPRAI

Leo Chiang Maintained (BABA) at Strong Buy with Increased Target to $160 on, Aug 8th, 2022

by: WOPRAI

Bret Jordan Maintained (AAP) at Strong Buy with Decreased Target to $220 on, Aug 8th, 2022

by: WOPRAI

Scott Devitt Maintained (ZG) at Hold with Decreased Target to $37 on, Aug 8th, 2022

by: WOPRAI

Scott Devitt Maintained (Z) at Hold with Decreased Target to $37 on, Aug 8th, 2022

by: WOPRAI

Madhu Kumar Maintained (ARWR) at Strong Buy with Increased Target to $65 on, Aug 8th, 2022

by: WOPRAI

Mark Strouse Maintained (ARRY) at Buy with Increased Target to $33 on, Aug 8th, 2022

by: WOPRAI

Mark Breidenbach Maintained (ARVN) at Buy with Decreased Target to $102 on, Aug 8th, 2022

by: WOPRAI

Dana Telsey Maintained (ARHS) at Buy with Decreased Target to $9 on, Aug 8th, 2022

by: WOPRAI

Marc Solecitto Maintained (ARIS) at Hold with Decreased Target to $18 on, Aug 8th, 2022

by: WOPRAI

Stephen Ju Maintained (APP) at Buy with Decreased Target to $80 on, Aug 8th, 2022

by: WOPRAI

Chris Kotowski Maintained (APO) at Buy with Increased Target to $61 on, Aug 8th, 2022

by: WOPRAI

Yi Chen Maintained (APDN) at Strong Buy with Increased Target to $160 on, Aug 8th, 2022

by: WOPRAI

Colin Rusch Maintained (APTV) at Buy with Decreased Target to $162 on, Aug 8th, 2022

by: WOPRAI

Mark Miller Downgraded (WDC) to Hold on, Aug 8th, 2022

by: WOPRAI

Patrick Ho Maintained (WDC) at Strong Buy with Decreased Target to $70 on, Aug 8th, 2022

by: WOPRAI

Jim Suva Maintained (WDC) at Strong Buy with Decreased Target to $60 on, Aug 8th, 2022

by: WOPRAI

Kevin Cassidy Maintained (WDC) at Hold with Decreased Target to $45 on, Aug 8th, 2022

by: WOPRAI

Vijay Rakesh Maintained (WDC) at Strong Buy with Decreased Target to $62 on, Aug 8th, 2022

by: WOPRAI

Joseph Moore Maintained (WDC) at Buy with Decreased Target to $65 on, Aug 8th, 2022

by: WOPRAI

Wamsi Mohan Maintained (WDC) at Strong Buy with Decreased Target to $60 on, Aug 8th, 2022

by: WOPRAI

Tristan Gerra Maintained (WDC) at Buy with Decreased Target to $55 on, Aug 8th, 2022

by: WOPRAI

Christian Schwab Maintained (WDC) at Strong Buy with Decreased Target to $85 on, Aug 8th, 2022

by: WOPRAI

Sidney Ho Maintained (WDC) at Strong Buy with Decreased Target to $56 on, Aug 8th, 2022

by: WOPRAI

James Goss Downgraded (WBD) to Hold on, Aug 8th, 2022

by: WOPRAI

Justin Long Maintained (WAB) at Buy with Increased Target to $110 on, Aug 8th, 2022

by: WOPRAI

Courtney Yakavonis Maintained (WAB) at Hold with Increased Target to $87 on, Aug 8th, 2022

by: WOPRAI

Simeon Gutman Maintained (W) at Sell with Decreased Target to $65 on, Aug 8th, 2022

by: WOPRAI

Courtney Yakavonis Maintained (WSC) at Buy with Increased Target to $50 on, Aug 8th, 2022

by: WOPRAI

David Anderson Maintained (WHD) at Buy with Decreased Target to $52 on, Aug 8th, 2022

by: WOPRAI

Michael Rehaut Maintained (WHR) at Buy with Decreased Target to $188 on, Aug 8th, 2022

by: WOPRAI

Andrew Charles Maintained (WING) at Buy with Increased Target to $150 on, Aug 8th, 2022

by: WOPRAI

Michael Leithead Maintained (WLK) at Hold with Decreased Target to $112 on, Aug 8th, 2022

by: WOPRAI

Neel Kumar Maintained (WLK) at Hold with Decreased Target to $115 on, Aug 8th, 2022

by: WOPRAI

Colin Langan Maintained (ADNT) at Buy with Increased Target to $45 on, Aug 8th, 2022

by: WOPRAI

Rod Hall Maintained (ADTN) at Hold with Increased Target to $24 on, Aug 8th, 2022

by: WOPRAI

Trey Grooms Maintained (ACA) at Buy with Increased Target to $70 on, Aug 8th, 2022

by: WOPRAI

Neena Bitritto-Garg Downgraded (ACAD) to Hold and Decreased Target to $15 on, Aug 8th, 2022

by: WOPRAI

Ritu Baral Maintained (ACAD) at Buy with Decreased Target to $21 on, Aug 8th, 2022

by: WOPRAI

Colin Rusch Maintained (ALB) at Buy with Increased Target to $440 on, Aug 8th, 2022

by: WOPRAI

David Begleiter Maintained (ALB) at Strong Buy with Increased Target to $270 on, Aug 8th, 2022

Justin Kim Downgraded (BCRX) to Hold on, Aug 8th, 2022

Justin Kim of Oppenheimer, Downgraded "BioCryst Pharmaceuticals, Inc." (BCRX) to Hold on, Aug 8th, 2022.

Justin has made no other calls on BCRX in the last 4 months.



There are 4 other peers that have a rating on BCRX. Out of the 4 peers that are also analyzing BCRX, all agree with Justin's Rating of Hold. Following are those relevant analyst calls for the last 4 months

  • Gena Wang of "Barclays" Maintained at Hold with Increased Target to $14 on, Friday, August 5th, 2022
  • Liisa Bayko of "Evercore ISI Group" Downgraded from Buy to Hold and Held Target at $14 on, Friday, August 5th, 2022
  • Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $14 on, Tuesday, April 12th, 2022
  • Tazeen Ahmad of "B of A Securities" Downgraded from Strong Buy to Hold and Held Target at $14 on, Monday, April 11th, 2022

Like: 👍